Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells

International Immunology

Volumn 20, Issue 4, 2008, Pages 565-575

  Vitale, Chiara ^a,c   Cottalasso, Francesca ^a   Montaldo, Elisa ^a   Moretta, Lorenzo ^a,b   Mingari, Maria Cristina ^a,b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Glucocorticoids; Lymphocyte differentiation; NK cells

Indexed keywords

CD161 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 13; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN P46; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT VERSUS HOST DISEASE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DOWN REGULATION; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MEDICAL RESEARCH; MYELOID PROGENITOR CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; UMBILICAL CORD BLOOD;

ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, CD34; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CYTOKINES; FEMALE; FETAL BLOOD; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-8; KILLER CELLS, NATURAL; METHYLPREDNISOLONE;

EID: 41149123860     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn014     Document Type: Article

References (48)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
2. Cerwenka, A. and Lanier, L. L. 2001. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1:41.
3. Moretta, L., Ciccone, E., Mingari, M. C., Biassoni, R. and Moretta, A. 1994. Human natural killer cells: Origin, clonality, specificity, and receptors. Adv. Immunol. 55:341.
4. Moretta, A., Bottino, C., Vitale, M. et al. 1996. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14:619.
5. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17:875.
6. Moretta, A., Bottino, C., Vitale, M. et al. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197.
7. Moretta, L. and Moretta, A. 2004. Unravelling natural killer cell function: Triggering and inhibitory human NK receptors. EMBO J. 23:255.
8. Moretta, A., Biassoni, R., Bottino, C., Mingari, M. C. and Moretta, L. 2000. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunol. Today. 21:228.
9. Bauer, S., Groh, V., Wu, J. et al. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:727.
10. Pende, D., Cantoni, C., Rivera, P. et al. 2001. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur. J. Immunol. 31:1076.
11. Bottino, C., Moretta, L., Pende, D., Vitale, M. and Moretta, A. 2004. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol. Immunol. 41:569.
12. Bottino, C., Castriconi, R., Pende, D. et al. 2003. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198:557.
13. Sivori, S., Parolini, S., Falco, M. et al. 2000. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30:787.
14. Vitale, M., Falco, M., Castriconi, R. et al. 2001. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31:233.
15. Parolini, S., Bottino, C., Falco, M. et al. 2000. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192:337.
16. Bottino, C., Falco, M., Parolini, S. et al. 2001. NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:235.
17. Miller, J. S. and McCullar, V. 2001. Human natural killer cells with polyclonal lectin and immonuglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. Blood. 98:705.
18. Sivori, S., Falco, M., Marcenaro, E. et al. 2002. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA. 99:4526.
19. Sivori, S., Cantoni, C., Parolini, S. et al. 2003. IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33:3439.
20. Grzywacz, B., Kataria, N., Sikora, M. et al. 2006. Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells. Blood. 108:3824.
21. Freud, A. G., Yokohama, A., Becknell, B. et al. 2006. Evidence for discrete stages of human natural killer cell differentiation in vivo. J. Exp. Med. 203:1033.
22. Freud, A. G. and Caligiuri, M. A. 2006. Human natural killer cell development. Immunol. Rev. 214:56.
23. Vitale, C., Pitto, A., Benvenuto, F. et al. 2000. Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors. Hematol. J. 1:136.
24. Shilling, H. G., McQueen, K. L., Cheng, N. W., Shizuru, J. A., Negrin, R. S. and Parham, P. 2003. Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation. Blood. 101:3730.
25. Vitale, C., Chiossone, L., Morreale, G. et al. 2004. Analysis of the activating receptors and cytolytic function of human natural killer cells undergoing in vivo differentiation after allogeneic bone marrow transplantaton. Eur. J. Immunol. 34:455.
26. Cooley, S., McCullar, V., Wangen, R. et al. 2005. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood. 106:4370.
27. Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A. and Caligiuri, M. A. 2002. Natural killer cell receptors: New biology and insights into the graft-versus-leukemia effect. Blood. 100:1935.
28. Costello, R. T., Fauriat, C., Sivori, S., Marcenaro, E. and Olive, D. 2004. NK cells: Innate immunity against hematological malignancies? Trends Immunol. 25:328.
29. Ruggeri, L., Mancusi, A., Capanni, M., Martelli, M. F. and Velardi, A. 2005. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr. Opin. Immunol. 17:211.
30. Ruggeri, L., Capanni, M., Urbani, E. et al. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 295:2097.
31. Ruggeri, L., Capanni, M., Casucci, M. et al. 1999. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood. 94:333.
32. Ruggeri, L., Aversa, F., Martelli, M. F. and Velardi, A. 2006. Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. Immunol. Rev. 214:202.
33. Giebel, S., Locatelli, F., Lamparelli, T. et al. 2003. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood. 102:814.
34. Vitale, C., Chiossone, L., Cantoni, C. et al. 2004. The corticosteroid-induced inhibitory effect on NK cell function reflects downregulation and/or dysfunction of triggering receptors involved in natural cytotoxicity. Eur. J. Immunol. 34:3028.
35. Chiossone, L., Vitale, C., Cottalasso, F. et al. 2007. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: Evidence for different susceptibility of IL-2- versus IL-15-activated NK cells. Blood. 109:3767.
36. Perez, S. A., Mahaira, L. G., Demirtzoglou, F. J. et al. 2005. A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival. Blood. 106:158.
37. Perez, S. A., Mahaira, L. G., Sotiropoulou, P. A. et al. 2006. Effect of IL-21 on NK cells derived from different umbilical cord blood populations. Int. Immunol. 18:49.
38. Pende, D., Parolini, S., Pessino, A. et al. 1999. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J. Exp. Med. 190:1505.
39. Poggi, A., Costa, P., Morelli, L. et al. 1996. Expression of human NKRP1A by CD34+ immature thymocytes: NKRP1A-mediated regulation of proliferation and cytolytic activity. Eur. J. Immunol. 26:1266.
40. Cantoni, C., Bottino, C., Vitale, M. et al. 1999. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J. Exp. Med. 189:787.
41. Bennett, I. M., Zatsepina, O., Zamai, L., Azzoni, L., Mikheeva, T. and Perussia, B. 1996. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. J. Exp. Med. 184:1845.
42. Loza, M. J. and Perussia, B. 2001. Final steps of natural killer cell maturation: A model for type 1-type 2 differentiation? Nat. Immunol. 2:917.
43. Loza, M. J., Zamai, L., Azzoni, L., Rosati, E. and Perussia, B. 2002. Expression of type 1 (interferon gamma) and type 2 (interleukin-13, interleukin-5) cytokines at distinct stages of natural killer cell differentiation from progenitor cells. Blood. 99:1273.
44. Perez, S. A., Sotiropoulou, P. A., Gkika, D. G. et al. 2003. A novel myeloid-like NK cell progenitor in human umbilical cord blood. Blood. 101:3444.
45. Hanna, J., Goldman-Wohl, D., Hamani, Y. et al. 2006. Decidual al NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12:1065.
46. Vacca, P., Pietra, G., Falco, M. et al. 2006. Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood. 108:4078.
47. Graf, T. 2002. Differentiation, plasticity of hematopoietic cells. Blood. 99:3089.
48. Katsura, Y. 2002. Redefinition of lymphoid progenitors. Nat. Rev. Immunol. 2:127.